- Home
- VSCO vs MNKD Comparison
VSCO vs MNKD Comparison
Compare VSCO & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSCO
- MNKD
- Stock Information
- Founded
- VSCO 1977
- MNKD 1991
- Country
- VSCO United States
- MNKD United States
- Employees
- VSCO N/A
- MNKD N/A
- Industry
- VSCO Clothing/Shoe/Accessory Stores
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- VSCO Consumer Discretionary
- MNKD Health Care
- Exchange
- VSCO Nasdaq
- MNKD Nasdaq
- Market Cap
- VSCO 1.8B
- MNKD 1.6B
- IPO Year
- VSCO N/A
- MNKD 2004
- Fundamental
- Price
- VSCO $18.37
- MNKD $4.98
- Analyst Decision
- VSCO Hold
- MNKD Buy
- Analyst Count
- VSCO 12
- MNKD 6
- Target Price
- VSCO $33.00
- MNKD $8.92
- AVG Volume (30 Days)
- VSCO 6.0M
- MNKD 2.0M
- Earning Date
- VSCO 03-05-2025
- MNKD 05-07-2025
- Dividend Yield
- VSCO N/A
- MNKD N/A
- EPS Growth
- VSCO 47.48
- MNKD N/A
- EPS
- VSCO 2.05
- MNKD 0.10
- Revenue
- VSCO $6,230,000,000.00
- MNKD $285,504,000.00
- Revenue This Year
- VSCO $2.17
- MNKD $14.66
- Revenue Next Year
- VSCO $2.12
- MNKD $14.27
- P/E Ratio
- VSCO $8.88
- MNKD $49.50
- Revenue Growth
- VSCO 0.78
- MNKD 43.50
- 52 Week Low
- VSCO $15.12
- MNKD $3.97
- 52 Week High
- VSCO $48.73
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- VSCO 31.30
- MNKD 36.48
- Support Level
- VSCO $17.62
- MNKD $4.89
- Resistance Level
- VSCO $21.63
- MNKD $5.12
- Average True Range (ATR)
- VSCO 1.16
- MNKD 0.13
- MACD
- VSCO 0.35
- MNKD 0.00
- Stochastic Oscillator
- VSCO 24.87
- MNKD 21.82
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime. The Company operates as a single segment designed to serve customers worldwide seamlessly through stores and online channels.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.